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Characterization of a plasminogen activator and its inhibitor in human
mesangial cells. In the course of some pathological and experimental
nephropathies, intragiomerular fibrin deposits develop, possibly as a
consequence of inefficient fibrinolysis. In vitro human glomeruli exhibit
fibrinolytic activity due to the synthesis of plasminogen activators (PAs)
such as, tissue-type PA (t-PA) and urokinase-type PA (u-PA). Immu-
nofluorescence studies have previously shown that t-PA is localized in
the capillary tufts and u-PA in the visceral epithelial cells. We have now
investigated the fibrinolytic activity of cultured human mesangial cells.
Inhibitory activity towards u-PA or t-PA but not plasmin was found in
both conditioned medium and cellular extracts. Analysis of the condi-
tioned medium by zymography revealed a single band of PA-activity
(Mr: 110 to 120 kDa). Immunoneutralization with anti-t-PA and anti-
plasminogen activator inhibitor (PAI-l) tgG but not anti-u-PA or
anti-PAI-2 removed this band. Reverse fibrin autography demonstrated
the presence of PAl- I in both cellular extracts and in conditioned
medium, Western Blot analysis showed that two bands (50 kD and 120
kD) were recognized by the anti-PAI-l antibody. By ELISA t-PA and
PAl- I antigens were found to increase progressively with time in the
culture medium but not in cellular extracts. Both t-PA and PAl-I, but
not u-PA and PAI-2, were also detected by immunofluorescence
studies. Thus human glomerular mesangial cells synthesize and secrete
t-PA and PAI-l in vitro. PAL-i is produced in excess, therefore t-PA is
only found in the form of a complex with PAl-I.
U-PA and t-PA are specific serine proteases that convert the
blood plasma zymogen plasminogen into the trypsin-like prote-
ase plasmin. One substrate of plasmin is fibrin, the solid support
of the blood clot. Plasmin is inactivated by the plasma protease
inhibitor a2-antiplasmin [1]. Likewise two specific plasminogen
activator inhibitors (PAls) have been obtained in a purified
form: PAT-i, first purified from bovine endothelial cell-condi-
tioned media [2, 3] and PAI-2 purified from human placenta [4,
5] and conditioned media of U-937 human histiocytic lymphoma
cells [6]. It has previously been shown that glomeruli produce
t-PA and also small amounts of u-PA activity [7—9]. Immuno-
histochemically, t-PA antigen was detected in the endothelial
cells of renal arterioles and in the glomerular tuft [7]. U-PA
antigen was detected in the epithelial cells of convoluted
tubules [10] and human glomerular epitbelial cells in culture [7].
Mesangial cells exhibit a specific phenotype only found in the
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glomerulus. They express characteristics of both smooth mus-
cle cells and monoeyte/maerophages [11]. Vascular smooth
muscle cells from calf aorta produce and release PAl activity
[12]. Cultured human monocytes/macrophages secrete pro-
urokinase and concomitantly release specific PAl [13]. Here we
demonstrate the presence of t-PA and PAT-i in human cultured
mesangial cells.
Methods
Materials
The following materials were obtained from the indicated
sources: collagenase type IV and Triton X 100 (Sigma Chemical
Co., St. Louis, Missouri, USA), bovine thrombin from Hoff-
man-Laroche (Basel, Switzerland), low melting point agarose
from BRL (USA), polyvinyl chloride U microtiter plates from
Dynateeh Laboratories (Alexandria, Virginia, USA), purified
human fibrinogen, plasminogen, plasmin and a synthetic sub-
strate D-Val-Leu-Lys-pNA (S-225 1) from AB Kabi (Stockholm,
Sweden), human urokinase reference standard grade from
Choay (Paris, France), human t-PA (600 000 U/mg), rabbit
polyclonal anti-human t-PA and anti-human u-PA antibodies
from Biopool (Sweden), monoclonal anti-human PAT-i antibod-
ies (I 105 and I 201) from Monozyme (Lyngby, Sweden),
anti-mouse IgG coupled to peroxidase, streptavidine coupled to
peroxidase, ophenylene diamine from Amersham (UK), and
Biotin was from Calbiochem (La Jolla, California, USA). Puri-
fied human PAl-i (100 ig/ml) and polyclonal rabbit anti-PAT-i
antibodies were provided by E.K.O. Kruithof (Lausanne).
Isolation of glomeruli
Glomeruli were isolated according to Striker's method [14].
In brief, thin (2 to 4 mm) strips of deeapsulated kidney cortex
were minced in culture medium. Small fragments of tissue were
pushed through 90-mesh stainless steel screens with a glass
pestle. The resulting mixture containing glomeruli was then
passed over a graded series of screens, and single, unencapsu-
lated glomeruli were finally retained on a fine mesh screen,
washed and sedimented in basal medium. These steps resulted
in a preparation of glomeruli virtually free of nonglomerular
contaminants.
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Mesangial cell cultures
For isolation of contractile mesangial cells [14], isolated
glomeruli were digested by collagenase type IV (750 U/mi) for
30 minutes. The glomerular suspension was sieved over a
stainless mesh screen and isolated epithelial cells were recov-
ered in the filtrate after repeated washings. The remaining
glomerular fragments were recovered and explanted in 10 mm,
Petri's dishes in complete Waymouth's medium supplemented
with 20% fetal calf serum. The glomeruli were incubated at 37°C
in a humidified 5% CO2 incubator. By this method, smooth
muscle-like mesangial cells appeared from the glomeruli ap-
proximately 8 to 14 days following attachment. They have been
previously characterized by morphological and biochemical
properties [11]. In order to eliminate any contamination by
either epithelial or endothelial cells, all experiments were
performed between the third and fifth passages. Furthermore,
immunofluorescence studies with specific polyclonal antibody
raised against Von Willebrand factor were negative, and re-
cently in our laboratory they have been shown to synthesize
prorenin [15].
Experiments were performed at cell confluency (cell density
4. l0 cells/cm2) after a 24-hour incubation time in complete
Waymouth's medium without FCS either on cell supernatants
centrifugated and supplemented with Triton X 100 from Sigma
(final concentration 0.1%) or on cellular extracts. Cellular
extracts were obtained after mechanical scrapping of the cells,
incubation in Triton X 100 (0.1%), followed by centrifugation to
remove cellular debris.
Assay of fibrinolytic activity and inhibitor activity
Fibrinolytic activity was measured by a chromogenic assay
as previously described [7]. Cell supernatant or extract (80 d)
were added to 20 p1 of Tris HC1 buffer pH 7.4 containing
plasminogen 0.4 tM and D-Val-Leu-Lys pNA, S2251, 2 m, a
synthetic chromogenic substrate of plasmin. When indicated
polylysin was also added to enhance t-PA activity as reported in
[16]. Optical density (OD) at 405 nm was measured in a
microelisa reader (Titerteck Multiskan MCC/340, Flow Labo-
ratories) after a one hour incubation at 37°C. Inhibitor activity
was measured as follows: exogenous urokinase (0 to 5 U/ml)
was incubated for 15 minutes at 37°C with Tris buffer pH 7.4
0.02% SDS and 0.2% Triton X 100 or with the inhibitor sample
made 0.02% SDS and 0.2% Triton X 100 in Tris buffer pH 7.4.
Twenty microliters of plasminogen and S225 1 were then added
to measure the residual u-PA activity. The culture medium used
in these experiments (Waymouth's medium) did not affect u-PA
activity, nor did medium containing 0.02% SDS and 0.2%
Triton X 100. Similarly, exogenous t-PA (0 to 5 U/ml) or
plasmin (0 to 100 mU/ml) were incubated with the samples to be
tested for a t-PA inhibitor or a plasmin inhibitor.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and zymography
After separation by 10% SDS polyacrylamide gel electropho-
resis according to Laemmli [17], plasminogen activator activity
was detected on a fibrin-agar underlay containing plasminogen
(fibrinogen 10 mg/ml, thrombin 300 mU/ml, agarose 1%, plas-
minogen 20 pg/ml) as previously described by Van Mourik,
Lawrence and Loskutoff [3]. Incubation was performed at 37°C
under humidified atmosphere. Molecular weight was deter-
mined with molecular standard on a gel stained with Coomassie
blue dye. Standard commercial human urokinase and tPA were
also run in the gel for zymography.
To detect plasminogen activator inhibitors by reverse fibrin
autography [3] u-PA or t-PA (0.1 U/ml final concentration) was
added to the fibrin agar underlay containing 20 tgIml plasmin-
ogen. Progressive lysis of the fibrin film was observed after
incubation at 37°C, except at the place of plasminogen activator
inhibitor.
When indicated, samples to be studied were diluted with goat
polyclonal anti-u-PA IgG or anti-t-PA IgG (10 g/ml, final
concentration) or with rabbit anti-PAl- 1 or anti-PAI-2 antisera
(dilution 1/10). After a 30 minute incubation at 37°C, an aliquot
of the antigen antibody mixture was analyzed by SDS-PAGE
and zymography. Control experiments were performed using
commercial human t-PA and u-PA to verify the specificity of the
antibodies.
Immunofluorescence studies
Cells were fixed for three minutes in acetone. Goat anti-u-PA
and goat anti-t-PA antibodies, and rabbit anti-PAI-l and anti-
PAI-2 antibodies were separately overlaid on cells and incu-
bated for 30 minutes at 22°C. Following three washes in PBS
(0.01 M sodium phosphate pH 7.4, 0.15 M NaCl) the specimens
were incubated either in presence of fluorescein isothiocyanate
labelled anti-goat Ig or fluorescein isothiocyanate labelled anti-
rabbit IgG. Controls were treated only with the labelled immu-
noglobulins. After washing three times with PBS the slides were
mounted in 50% glycerol in PBS and examined using a Carl
Zeiss Fluorescence microscope with epi-illumination (Carl
Zeiss, Jena, FRG).
Immunoblotting
After SDS-PAGE the proteins were transferred to a nitrocel-
lulose sheet by a five hour electrophoresis at 250 mA in 25 mM
Tris-HC1 and 150 mM glycine, pH 8.3, containing 20% metha-
nol. The sheet was washed with water, subsequently incubated
2 x 30 minutes at 37°C in 1.75% gelatin (Prolabo), and overnight
in 40 ml PBS, 1% Tween containing 10 tg/ml of two purified
anti-PAl-i monoclonal antibodies. After three washings in PBS
1% Tween, the sheet was transferred to a four hour incubation
at 22°C in PBS 1% Tween containing goat anti-mouse IgG
conjugated with horseradish peroxidase (Bio Rad), employing a
dilution of 1/200. After three washings in PBS, peroxidase
staining was performed with BioRad staining reagent according
to the instructions of the manufacturer.
Enzyme linked immunosorbent assay (ELISA)
Microtiter polyvinylchloride plates were coated with specific
rabbit anti-human PAl-i antiserum (EKO Kruithof, Lausanne,
Switzerland): 120 p1 of antiserum diluted 1:5000 in 0.1 M
bicarbonate buffer pH 9.4 were incubated for 18 hours at 4°C.
After three washings with (phosphate-buffer saline, pH 7.2)
PBS-Tween 0.1%, 100 p1 of the samples to be tested were added
for two hours at 37°C. After five washings with PBS Tween
0.1%, two 5 g/ml anti-PAl-i monoclonal antibodies were
added for two hours at 37°C. The plates were then washed with
PBS Tween and incubated with diluted horseradish peroxidase
coupled with anti-mouse IgG (1/1000) for one hour at 22°C,
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Thereafter the plates were emptied, washed with PBS Tween
and developed by the addition of 100 d of 1 mg/mI o-phenylene
diamine and 100 d of 0.1% hydrogen peroxide. The reaction
was stopped after 30 minutes at room temperature by addition
of 30 d 8 N H2S04. Absorbance at 492 nm was measured with
a Multiscan spectrophotometer (Titerteck, Flow Laboratories,
Irvine, Scotland). An ELISA of t-PA using polyclonal goat
anti-human t-PA IgG (Biopool, Sweden) was also done. Plates
were coated with a 5 g/m1 solution of this antibody. After
addition of the samples to be tested, incubation and washing,
anti-t-PA antibodies biotinylated as described in [181 were
added for two hours at 37°C. The plates were then washed, and
incubated with diluted horseradish peroxidase coupled with
streptavidine for one hour at 22°C. Thereafter the reaction was
developed as for PAl- 1. The concentrations of PAl- 1 and t-PA
were determined with standard curves established with purified
PA!-! and commercial t-PA. The interassay variations were
respectively 15% and 12%. The intraassay variations were less
than 10%. The lowest concentrations that could be detected
were 6 ng/ml for PA!-! and 0.04 U/mi (or 440 pg/mi) for t-PA.
Results
PA activity
No PA activity could be detected by the spectrophotometric
assay in the culture medium conditioned by human mesangial
cells for 24 hours, whether or not polylysin was added. On the
other hand, conditioned medium contained inhibitory activity
towards u-PA or t-PA but not plasmin (Fig. 1). Preincubation of
exogenous u-PA (0 to 5 U/rn!) or t-PA (0 to 5 U/mi) with
mesangial supernatants resulted in a decrease of their enzy-
matic activity, whereas plasmin activity (0 to 100 mU/mi) was
not affected.
Fig. 1. Inhibition of plasminogen activator
activity by mesangial 24-hour conditioned
culture medium. A. t-PA (0 to 5 U/mI). B.
Urokinase (0 to 5 U/mi). C. Piasmin (0 to 100
mU/mi) were incubated with Tris HC1 buffer
pH 7.4, 0.02% SDS, 0.2% ml Triton X 100 (•)
or the sample to be tested (•). Then
plasminogen and S225 1 were added and the
chromogenic reaction was measured after one
hour at 37°C. Results are expressed in optical
density. Each point represents the mean of
two separate experiments.
Fig. 2. Zymographic analysis of mesangial cells in conditioned me-
dium. In panel A standard t-PA and u-PA were used. Lane 1: t-PA (1 UI
ml), lane 2: t-PA (1 U/mi) + anti-t-PA (10 g/ml), lane 3: u-PA (2 U/mI),
lane 4: u-PA (2 U/mI) + anti-u-PA (10 ig/ml), lane 5: t-PA + anti-PAl-i
antibody, lane 6: u-PA + anti-PAl-i antibody. In panel B mesangial
24-hour conditioned culture medium (protein concentration 100 g/ml)
was analyzed. It was added with buffer (lane 1), anti-u-PA antibodies 10
g/ml (lane 2), anti-t-PA antibodies 10 g/ml (lane 3), anti-PAl-I
antiserum 1/10 (lane 4) and anti-PAI-2 antiserum 1/10 (lane 5).
Zymography
After a 24 hour incubation, conditioned medium contained a
high molecular weight form (120 kD) of PA activity which
completely disappeared when the samples to be studied have
been preincubated with anti-t-PA or with anti-PAI-l antibodies.
No effect was observed with either anti-u-PA or anti-PAI-2
antibody pretreatment (Fig. 2).
The presence of a PA! in cells supernatants and in cellular
extracts of human glornerular mesangial cells was also shown
by reverse fibrin autography (Fig. 3A). It was found in a low Mr
form of about 55 kD in cell supernatants and cellular extracts.
Similar results were obtained with fibrin agar underlay contain-
ing either u-PA (photography) or t-PA (not shown).
Immunoblot analysis
Immunoblot analysis of fivefold concentrated cell superna-
tants of glornerular mesangial cells for PAI-l confirmed these
results and also demonstrated at least two different forms of
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Fig. 3A. Reverse fibrin auto graphy of cellular extracts (lane 1), and
24-hour conditioned medium (lane 2) of human cultured mesangial
cells. The active form of PAL was present in both samples as demon-
strated by the 55 kD lysis-resistant area. B. Immunoblot analysis of 35
l of fivefold concentrated conditioned medium of mesangial cells (lane
I) and of purified PAl-I (lane 2). After transfer to nitrocellulose,
immunochemical staining was performed using two monoclonal anti-
PAT-I antibodies and anti-mouse IgG antibodies conjugated with horse-
radish peroxidase. Molecular weights of the proteins detected are given
at the left.
PAl-i, one doublet at a Mr of 50 to 55 kD and another of about
120 kD (Fig. 3B). Immunoblot analysis performed with anti-
PAI-2 serum was negative (not shown).
Immunofluorescence studies
No immunofluorescence staining was observed with polyclo-
nal anti-u-PA or anti-PAI-2 IgG. However, as shown in Figure
4, the same studies employing polyclonal anti-t-PA IgG or
anti-PAl-i antiserum yielded positive signals. The staining
pattern with anti-PAI-l was more diffuse than with anti-t-PA,
which was mostly perinuclear.
ELISA
Finally by ELISA we were able to show a progressive
time-dependent increase of PAI-l antigen in the conditioned
culture medium and also a progressive increase in t-PA antigen,
whereas the cellular content was stable (Fig. 5). Standard t-PA
had a specific enzymatic activity of 600,000 U/mg protein. Thus
t-PA amounts in the conditioned culture medium varied from 0
to 10 ng/ml and t-PA/PAI- 1 molar ratio increased from 1:200 at
eight hours to 1:60 at 24 and 48 hours of incubation. However,
PAl-i antigen was always found far in excess when compared
to t-PA antigen.
Fig. 4. Immunofluorescence of mesangial cells. A. Treatment with
goat anti-t-PA and fluorescent anti-goat 1g. B. Treatment with rabbit
serum anti-PAI-l and fluorescent anti-rabbit Ig (x 850). C and D.
Controls only treated with fluorescent anti-goat Ig and anti-rabbit Ig,
respectively.
Discussion
Intraglomerular fibrin deposits, which appear in the course of
numerous pathological and experimental nephropathies, may
be caused by a locally-defective fibrinolytic system, and it is
established that such fibrin deposits play a pathogenic role [19].
a.--
A
B
12
rae
1 2
810 Lacave et a!: Plasminogen activator in human mesangial ce/Is
24 32
Time, hours
Fig. 5. Time course study of t-PA and PAl-I antigens measured by
ELISA. A. t-PA in culture medium (I), t-PA in cellular extract (•),
total synthesized t-PA (A). B. Symbols are: PAl-I in culture medium
(•), PAI-l in cellular extract (•), total synthesized PAl-i (A).
However, the molecular mechanism(s) causing deficient gb-
merular fibrinolysis is still unclear.
Our studies demonstrate that cultured human glomerular
mesangial cells can synthesize and release both a tissue-type
plasminogen activator and a plasminogen activator inhibitor
immunologically related to PA!-!. No plasminogen activator
activity could be detected in the conditioned culture medium by
the chromogenic assay whether or not polylysin was used. An
inhibitory activity toward u-PA and t-PA was found. Since no
inhibition of plasmin was observed, an effect of a2 anti-plasmin,
a1 trypsin inhibitor, heparin-antithrombine III complex or C1
esterase inhibitor could be excluded [11. There are two specific
PAls: PAT-i has been found in human plasma [20—22] and in
human platelets [23], and has been shown to be produced by
human and bovine cultured endothelial cells [2, 3, 241, human
fibroblasts [25, 26] and HTC rat hepatoma cells [27, 28]; PAI-2,
originally purified from placental extracts [4, 5], was also found
to be produced by human and murine macrophages [13, 29] and
more recently by the human histiocytic lymphoma cell line
U-937 [6, 30]. In this cell line it is concomitantly produced with
pro-urokinase, as in human monocytes-macrophages [13]. In
our study, the PAl produced by cultured human glomerular
mesangial cells is related to PAI-l because: 1) specific anti-PAl-
I antibodies bound to mesangial PAl; and 2) the molecular
weight estimated by immunoblotting and reverse fibrin autog-
raphy is in agreement with that of PAl-i [2, 24]. t-PA is
covalently linked to the specific inhibitor in a complex of 110 to
120 kD. This finding has been previously reported for PAl-I in
whole human plasma [20], in both human and bovine cultured
endothelial cells [2, 24] and in hepatocytes and Hep G2 hepa-
toma rat cell line [31]. As reported by Levin [24] and Loskutoff
et al [2] this covalent complex is stable in presence of SDS.
Thus, human glomerular mesangial cells synthesize both t-PA
and PAI-l. PAl-i is synthesized and secreted in large excess as
demonstrated by the t-PA/PAI- 1 molar ratio ranging from 1:200
to 1:60. This explains: 1) the lack of t-PA activity in cellular
extracts and conditioned media; 2) the single 110 to 120 kD lysis
band on zymography; and 3) the presence of free PAl-i
observed by reverse fibrin autography in cell supernatants and
cellular extracts.
In this respect, human glomerular mesangial cells in vitro
resemble more vascular smooth muscle cells which produce
PAl-i [12] than monocyte-macrophages which produce both
u-PA and PAI-2 but not PAl-i [13]. It has been suggested that
PAl- 1 plays an important role protecting the basement mem-
brane from proteolytic degradation by plasmin-generating en-
zymes [32], and that PAI-l represents a major protein deposited
beneath human lung fibroblasts [33], fibrosarcoma cells [34] and
endothelial cells in culture, being detected in the growth sub-
stratum before its appearance in conditioned medium [35]. It is
likely that mesangial PAI-l plays a similar role in the mesan-
gium, the integrity of which is necessary for a normal renal
function. It may also play a part in the local proteolytic control
of connective tissue turnover, coagulation, fibrinolysis, com-
plement activation and inflammatory reactions.
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